Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shire BioChem Inc.

Division of Takeda Pharmaceutical Co. Ltd.

Latest From Shire BioChem Inc.

Shire: Proving the Specialty Model

As generics circle over Adderall XR, Shire's management must prove that the firm's original "search & development" model can still work.
BioPharmaceutical Strategy

PSA 2004: Looking to the Sustainable Middle

If the nominal theme of Windhover's 2004 Pharmaceutical Strategic Alliances conference was "transitions", the full subtext was "transitions to sustainability." Mid-sized players appear to have the best shot at sustainability in an environment where, increasingly, less differentiated, primary care blockbusters are out, and specialist products are in.
BioPharmaceutical Strategy

Biotech's Euro-Marketing Gambit

Europe presents a big opportunity--but also significant challenges--to niche players seeking to expand. Some firms--such as US group Cephalon--have bought big in Europe, others like Shire and Celltech have made do with smaller acquisitions onto which they hope to build their own tailored infrastructure. No single approach is the same, and none has yet proven a clear winner. But all depend on finding the right products.
BioPharmaceutical Strategy

University Of Alberta Industry Liaison Office

For the University of Alberta, new company creation fulfills a mission of protecting intellectual property for the benefit of Canadian society, a goal that comes even before its desire to take in revenues to help offset research costs. The university has created 40 spin-offs in life sciences.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Nasal
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • BioChem Pharma Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Joseph Rus, Pres. & CEO
    Frederick J Andrew, CFO
    Gervais Dionne, PhD, EVP, R&D
    Daniel Hetu, MD, VP, Corp. Dev.
  • Contact Info
  • Shire BioChem Inc.
    Phone: (514) 787-2300
    2250 Alfred-Nobel Blvd.
    Bureau 500
    Saint-Laurent, H4S 2C9